BTT-369
BTT-369 is a CaVα1·CaVβ3 protein-protein complex antagonist with a Ki of 2.0 μM. BTT-369 inhibits CaV2.2 currents, with an apparent IC50 value of 31 μM. BTT-369 disrupts the interaction between CaVα1 and CaVβ3 subunits. BTT-369 reduces the current density of CaV2.2, and shifts the voltage dependence of steady-state inactivation and activation of CaV2.2 to more positive potentials. BTT-369 alleviates mechanical hyperalgesia in a rat model of tibial nerve injury. BTT-369 can be used for the study of neuropathic pain.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2413939-96-3
- Formel: C34H28N8O2
- Molecular Weight:580.64
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Calcium Channel Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
CaV2.2 31 μM (IC50) |
In Vitro
BTT-369 potently inhibits the protein-protein interaction between purified CaVα1-AID and CaVβ3, with a Ki value of 2.0 μM[1].
BTT-369 (0.1-100 μM; 5 min-48 h) reduces CaV2.2 current density in HEK-CaV2.2 cells, and shifts the voltage dependence of CaV2.2 activation and steady-state inactivation toward more positive potentials[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
In Vivo
Chemical Information
-
CAS. Nr. 2413939-96-3
-
Molecular Weight 580.64
-
Formel C34H28N8O2
-
SMILES
O=C(C1=CC=CC(C2=NN=NN2)=C1)N3N=C(C4=CC=C(OC)C=C4)CC3C5=CN(C6=CC=CC=C6)N=C5C7=CC=C(C)C=C7
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)